Evidence map›Paper›PMID 38135977›Full record

ArticleBioengineering (Basel, Switzerland)2023

Machine-Learning-Based Prediction of 1-Year Arrhythmia Recurrence after Ventricular Tachycardia Ablation in Patients with Structural Heart Disease.

Ferenc Komlósi, Patrik Tóth, Gyula Bohus, Péter Vámosi, Márton Tokodi, Nándor Szegedi, Zoltán Salló, Katalin Piros, Péter Perge, István Osztheimer and 5 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Ferenc KomlósiHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0003-3260-2471
Patrik TóthHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Gyula BohusHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Péter VámosiHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Márton TokodiHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0003-3036-4131
Nándor SzegediHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Zoltán SallóHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Katalin PirosHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0002-1428-3588
Péter PergeHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
István OsztheimerHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0002-8209-990X
Pál ÁbrahámHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-5645-9855
Gábor SzéplakiMater Private Hospital, 69 Eccles St., D07 WKW8 Dublin, Ireland.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
László GellérHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Klaudia Vivien NagyHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.
Semmelweis University · HUMater Misericordiae University Hospital · IE

Funding

Ministry for Innovation and Technology in Hungary 2020-4.1.1.-TKP2020National Research, Development and Innovation Fund of Hungary NVKP_16-1-2016-0017
6 · The paper itself

Abstract

backgroundVentricular tachycardia (VT) recurrence after catheter ablation remains a concern, emphasizing the need for precise risk assessment. We aimed to use machine learning (ML) to predict 1-month and 1-year VT recurrence following VT ablation.

methodsFor 337 patients undergoing VT ablation, we collected 31 parameters including medical history, echocardiography, and procedural data. 17 relevant features were included in the ML-based feature selection, which yielded six and five optimal features for 1-month and 1-year recurrence, respectively. We trained several supervised machine learning models using 10-fold cross-validation for each endpoint.

resultsWe observed 1-month VT recurrence was observed in 60 (18%) cases and accurately predicted using our model with an area under the receiver operating curve (AUC) of 0.73. Input features used were hemodynamic instability, incessant VT, ICD shock, left ventricular ejection fraction, TAPSE, and non-inducibility of the clinical VT at the end of the procedure. A separate model was trained for 1-year VT recurrence (observed in 117 (35%) cases) with a mean AUC of 0.71. Selected features were hemodynamic instability, the number of inducible VT morphologies, left ventricular systolic diameter, mitral regurgitation, and ICD shock. For both endpoints, a random forest model displayed the highest performance.

conclusionsOur ML models effectively predict VT recurrence post-ablation, aiding in identifying high-risk patients and tailoring follow-up strategies.

Indexed as

catheter ablationmachine learningrandom forestrecurrenceventricular tachycardia

Identifiers

PMID38135977
PMCPMC10740977
OpenAlexW4389274603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.